Diagnostics for Women's Health
SavranTech is a category-defining diagnostics company advancing breakthrough solutions for critical conditions in women’s health, beginning with preeclampsia. Our patented platform powers non-invasive, cell-based diagnostic tests across maternal health, prenatal care, and oncology.
$6M+
Funding secured for platform development and clinical advancement
10
Foundational publications
28
Issued patents worldwide in the North America, Europe, and Asia, protecting our devices and methods in major global markets
Why We Built SavranTech
We welcome collaboration with innovators, clinicians, and investors who share our mission to transform diagnostics in women’s health. Whether you have a question, a partnership idea, or a new opportunity, we’d love to hear from you.
Our team brings together deep scientific expertise, clinical insight, and entrepreneurial drive to advance the next generation of non-invasive diagnostics.
